Literature DB >> 8099527

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) disrupts social memory/recognition processes in the male mouse.

D E Dluzen1, J D Kreutzberg.   

Abstract

Male mice treated with MPTP or vehicle were tested for their ability to demonstrate a memory-recognition response as evaluated in a habituation-dishabituation task. Treatment with MPTP severely disrupted the male's habituation-dishabituation response profile compared to vehicle treated animals. Administration of L-DOPA at 45 min prior to behavioral testing in MPTP animals restored their performance on the habituation-dishabituation test to levels observed in vehicle treated animals. There was also a tendency for L-DOPA to produce enhanced responsiveness in vehicle treated animals. Mice treated with MPTP had significantly reduced concentrations of norepinephrine within the olfactory bulb and hippocampus. Vehicle treated mice administered L-DOPA had significantly increased dopamine concentrations within the corpus striatum. These results suggest that, in addition to its putative effects upon the nigrostriatal dopaminergic system and motor behavior, MPTP is also exerting substantial effects upon other systems. In particular, the noradrenergic system and its potential involvement with memory/recognition processes in the CD-1 mouse appears to be very sensitive to the neurotoxic effects of MPTP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099527     DOI: 10.1016/0006-8993(93)90860-p

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Chronic alcohol consumption from adolescence-to-adulthood in mice--effect on growth and social behavior.

Authors:  Hong Zou; Qinglian Xie; Manfang Zhang; Chenghao Zhang; Guoping Zhao; Meilei Jin; Lei Yu
Journal:  Drug Alcohol Depend       Date:  2009-06-27       Impact factor: 4.492

2.  Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex.

Authors:  Herbert E Covington; Mary Kay Lobo; Ian Maze; Vincent Vialou; James M Hyman; Samir Zaman; Quincey LaPlant; Ezekiel Mouzon; Subroto Ghose; Carol A Tamminga; Rachael L Neve; Karl Deisseroth; Eric J Nestler
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

3.  Cholinergic modulation of a decrement in social investigation following repeated contacts between mice.

Authors:  J T Winslow; F Camacho
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

4.  Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease.

Authors:  Eduardo L G Moreira; Daniel Rial; Aderbal S Aguiar; Cláudia P Figueiredo; Jarbas M Siqueira; Silvia DalBó; Heros Horst; Jade de Oliveira; Gianni Mancini; Tiago S dos Santos; Jardel G Villarinho; Francielle V Pinheiro; José Marino-Neto; Juliano Ferreira; Andreza F De Bem; Alexandra Latini; Moacir G Pizzolatti; Rosa M Ribeiro-do-Valle; Rui D S Prediger
Journal:  J Neural Transm (Vienna)       Date:  2010-10-08       Impact factor: 3.575

5.  Transcranial Magneto-Acoustic Stimulation Improves Neuroplasticity in Hippocampus of Parkinson's Disease Model Mice.

Authors:  Yuexiang Wang; Lina Feng; Shikun Liu; Xiaoqing Zhou; Tao Yin; Zhipeng Liu; Zhuo Yang
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

6.  Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson's disease.

Authors:  Rui D S Prediger; Argelia E Rojas-Mayorquin; Aderbal S Aguiar; Caroline Chevarin; Raymond Mongeau; Michel Hamon; Laurence Lanfumey; Elaine Del Bel; Hisako Muramatsu; José Courty; Rita Raisman-Vozari
Journal:  J Neural Transm (Vienna)       Date:  2011-02-08       Impact factor: 3.575

7.  Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Argelia Esperanza Rojas-Mayorquin; Claudia P Figueiredo; Filipe C Matheus; Laure Ginestet; Caroline Chevarin; Elaine Del Bel; Raymond Mongeau; Michel Hamon; Laurence Lanfumey; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2009-07-21       Impact factor: 3.911

8.  Modification of social memory, hypothalamic-pituitary-adrenal axis, and brain asymmetry by neonatal novelty exposure.

Authors:  Akaysha C Tang; Bethany C Reeb; Russell D Romeo; Bruce S McEwen
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

9.  Social memory in mice: disruption with an NMDA antagonist and attenuation with antipsychotic drugs.

Authors:  Xue-Min Gao; Gregory I Elmer; Beverley Adams-Huet; Carol A Tamminga
Journal:  Pharmacol Biochem Behav       Date:  2008-12-10       Impact factor: 3.533

10.  Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.

Authors:  Marta G Vucković; Ruth I Wood; Daniel P Holschneider; Avery Abernathy; Daniel M Togasaki; Alexandra Smith; Giselle M Petzinger; Michael W Jakowec
Journal:  Neurobiol Dis       Date:  2008-08-05       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.